Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today reported financial results for the third quarter ended ...

Q3 2025 Management View Ian Mortimer, President and CEO, highlighted three critical priorities: completion of the Phase III X ...

Absenteeism isn’t just about the occasional sick note, it’s a silent drain on South Africa’s economy. Research shows that ...

ASX-listed medtech companies have been rolling out their latest quarterly results, showing solid progress across key areas ...

In a pop-up city off the coast of Honduras, longevity startups are trying to fast-track anti-aging drugs. Is this the future ...

Q3 2025 Earnings Call Transcript October 30, 2025 Merit Medical Systems, Inc. beats earnings expectations. Reported EPS is $0 ...

Google Translate has always been a useful app for travelers abroad, but it has also rolled out a few improvements that people ...

Background/Aims The neuroprotective effect of nicotinamide (NAM) supplementation has been demonstrated in both animal models ...

1. Don't adjust your wake-up time straight after the time changes. After a few days to a week, your body will acclimate to the new time. Instead, consider taking a short 20-minute nap in the ...

Guardant Health, Inc. shows strong adoption and revenue growth in oncology and data. Click for my updated look at GH stock ...

Good afternoon, and welcome to Sarepta's Third Quarter 2025 Financial Results Conference Call. As a reminder, today's program is being recorded. At this time, I'll turn the call over to Tam Thornton, ...

Consolidated Revenue -- EUR 66.3 million, down 3.5% compared to Q3 2024, with Materialise Medical achieving an all-time ...